Comparing isotretinoin to standard care for moderate acne in darker skin
Treatments studied
Part of Skin clinical trials.
This trial compares oral isotretinoin (a strong acne medication) to standard treatments for people with moderate acne and darker skin tones. It aims to find which treatment works best for skin of color.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 13 and 30 years old
- You have a darker skin type (Fitzpatrick IV, V, or VI)
- Your acne is moderate (not mild, not severe)
- You have a cell phone that can take clear selfies (at least 5 megapixels)
- You have French health insurance (social coverage)
- You have not taken isotretinoin before, or oral antibiotics for acne in the last 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two different dosages of isotretinoin (a powerful acne medication) to see which works better and causes fewer side effects. Isotretinoin is typically used for acne that hasn't improved with other treatments.
This trial tests a weekly dose of isotretinoin (a strong acne medicine) versus a standard tetracycline antibiotic for treating moderate acne. It aims to find a simpler, effective option with fewer side effects.
This study tests whether balancing the bacteria on your skin can help treat mild to moderate acne. Researchers will take facial photos and follow your progress to see if this new approach works.
This trial tests three different gel treatments for mild to moderate acne on the face. One gel contains clindamycin and retinoid, another adds dexamethasone, and the third uses a special stem-cell secretion. All are applied to the face for 8 weeks.
This trial studies whether putting antibiotic creams on mild-to-moderate facial acne reduces inflammation. It may help answer whether topical erythromycin or clindamycin can improve acne-related redness and swelling.
This trial tests a treatment for dry eyes caused by isotretinoin, a drug used for severe acne. It aims to help people with moderate to severe acne who are already taking isotretinoin and experiencing dry eye symptoms.
Hear when a new Acne Vulgaris trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.